PMID- 12864989 OWN - NLM STAT- MEDLINE DCOM- 20031023 LR - 20190827 IS - 0165-5728 (Print) IS - 0165-5728 (Linking) VI - 140 IP - 1-2 DP - 2003 Jul TI - High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome. PG - 194-7 AB - Non-paraneoplastic Lambert-Eaton myasthenic syndrome (LEMS) is an antibody-mediated autoimmune disorder, in which genetically determined interleukin-10 (Il-10) and tumor necrosis factor-alpha (TNF-alpha) could play a role in the susceptibility for the disease. Therefore, we analyzed the production of Il-10 and TNF-alpha after whole-blood stimulation in first-degree family members of patients with LEMS without malignancy, as a measure of innate production in the patients. Thirty-six first-degree family members of 10 patients and 80 healthy controls were studied. Both Il-10 (p=0.037) and TNF-alpha (p=0.0016) production were increased in the family members, but had no relation with the severity of LEMS or HLA-B8DR3 carriership. Our findings suggest that high innate production of Il-10 and TNF-alpha is a susceptibility factor for non-paraneoplastic LEMS. FAU - Wirtz, Paul W AU - Wirtz PW AD - Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. pwwirtz@lumc.nl FAU - Huizinga, Tom W J AU - Huizinga TW FAU - Stoeken, Dirk-Jan AU - Stoeken DJ FAU - Wintzen, Axel R AU - Wintzen AR FAU - Verschuuren, Jan J AU - Verschuuren JJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Neuroimmunol JT - Journal of neuroimmunology JID - 8109498 RN - 0 (Tumor Necrosis Factor-alpha) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Adult MH - Disease Susceptibility/immunology MH - Female MH - Humans MH - Immunity, Innate/genetics MH - Interleukin-10/*biosynthesis MH - Lambert-Eaton Myasthenic Syndrome/genetics/*immunology MH - Male MH - Middle Aged MH - Tumor Necrosis Factor-alpha/*biosynthesis MH - Up-Regulation/genetics/*immunology EDAT- 2003/07/17 05:00 MHDA- 2003/10/24 05:00 CRDT- 2003/07/17 05:00 PHST- 2003/07/17 05:00 [pubmed] PHST- 2003/10/24 05:00 [medline] PHST- 2003/07/17 05:00 [entrez] AID - S0165572803002054 [pii] AID - 10.1016/s0165-5728(03)00205-4 [doi] PST - ppublish SO - J Neuroimmunol. 2003 Jul;140(1-2):194-7. doi: 10.1016/s0165-5728(03)00205-4.